Toggle search
Toggle menu
406
21
32
6.1K
Pharmacopedia
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Drilldown: Medicines

More actions

Choose a table:


Medicines > classes : Cathinone or Opioid or Sedative-hypnotic

Use the filters below to narrow your results.

generic:
Codeine (2)
brand:
None (35)
classes: (Click arrow to add another value)
mechanism:
GABAA positive allosteric modulator (15) · Potent mu-opioid receptor agonist (6) · Monoamine releasing agent (4) · Mu-opioid receptor agonist (4) · GABAA positive allosteric modulator (non-benzodiazepine) (3) · Serotonin/norepinephrine/dopamine releasing agent (3) · None (2) · Cathinone analogue; monoamine reuptake inhibitor (2) · GABAA potentiator and direct activator (2) · Melatonin receptor agonist (2)
uses:
None (74) · Mild to moderate pain; cough suppression (low-dose). (1) · No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1)
starting dose:
None (74) · Adult: 15–60 mg every 4 hours as needed. (1) · No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1)
preparations:
None (74) · Illicit tablets ("bars"), powders, blotter, occasionally solutions. No pharmaceutical product exists. (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)
fda max:
None (74) · 360 mg/day (1) · N/A (never approved) (1)
routes:
None (74) · intranasal; rectal and IV reported. (1) · Oral (1) · PO (only formulation marketed in the US). (1) · sublingual (1)
onset:
None (74) · 30–60 min (PO) (1) · ~20–40 min PO; faster sublingual/intranasal. (1)
duration:
None (74) · 4–6 hours (1) · 6–10 h subjective; full pharmacologic effect considerably longer. (1)
halflife:
None (74) · 2.5–3 hours (1) · Estimated ~12–17 h (some sources cite up to ~21 h); active metabolites prolong effect. (1)
bioavailability:
None (74) · Not formally characterized in humans. (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)
pregnancy:
None (74) · Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1)
legal:
None (75) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)

Showing below up to 76 results in range #1 to #76.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"